Regulatory & Legal

Nitinotes' robotic suturing system for weight loss arrives in Spain, promising a new, more accessible era for minimally invasive bariatric procedures.

With $10M from top VCs, Almanac Health is tackling AI's credibility crisis in medicine with a platform built on evidence, validation, and trust.

Backed by military funding, a novel protein therapy that actively grows bone has finished a key clinical trial, promising to revolutionize dental surgery.

The Health Research Foundation opens nominations for its equity award, spotlighting researchers who are closing critical health gaps for diverse communities.

With a physician shortage deepening across the US, two international medical schools just placed 97% of their graduates into residencies, many in underserved areas.

With a new board member and planned financing, LeoNovus is pushing ahead with its ambitious plan to revolutionize precious metals trading via blockchain.

10,000+ fans protest a new law capping ticket resale prices. The government claims it's for consumers, but critics say it fuels fraud and helps Ticketmaster.

Aflac is the American Cancer Society's Partner of the Year, a recognition highlighting its deep commitment as 90% of Americans delay vital screenings.

After a year of massive write-downs, the consumer goods giant charts a new course focused on growth, debt reduction, and operational resilience.

Mobileye raises its 2026 outlook after a strong Q1, but a massive non-cash charge highlights a complex financial picture for the AV tech leader.

The housing market is thawing as sellers finally let go of low mortgage rates, but a deep regional divide and rising climate risks create a complex new reality.

With Australian employers now facing jail time for wage theft, a new platform update from WageSafe aims to catch payroll errors before they become crimes.

A firm co-founded by hedge fund titan Kyle Bass is buying up 'mitigation banks,' turning ecological restoration into a high-stakes investment.

CNX champions a new era of real-time ESG reporting and local investment, but critics question the depth of its transparency and environmental claims.

TGA approves Minjuvi, a dual-targeted immunotherapy for relapsed follicular lymphoma, offering a breakthrough option beyond traditional chemotherapy.

As Materialise preps its Q1 2026 report, all eyes are on its booming medical unit to see if it can offset persistent industrial market weakness.

The life sciences advisory firm adds a heavy-hitter with $150B+ in deal experience, signaling ambitious growth and a new focus on the Southeast.

OSI Systems lands a major contract for over-the-horizon radar, a key technology poised to reshape long-range surveillance and national security strategy.

How a young firm won giants like DHL and ARD in two years by replacing filing cabinets with a simple sticker and a powerful digital compliance portal.

A new K-to-career charter school pathway opens in a former public school, testing a controversial state law and a community's hopes for the future.